{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388845304768000.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3945/an.116.013151"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S2161831322007141?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S2161831322007141?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.3945/an.116.013151"}}],"dc:title":[{"@value":"Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388845304768001","@type":"Researcher","foaf:name":[{"@value":"Zeinab Mokhtari"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845304768000","@type":"Researcher","foaf:name":[{"@value":"Deanna L Gibson"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845304767872","@type":"Researcher","foaf:name":[{"@value":"Azita Hekmatdoost"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"21618313"}],"prism:publicationName":[{"@value":"Advances in Nutrition"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-03","prism:volume":"8","prism:number":"2","prism:startingPage":"240","prism:endingPage":"252"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S2161831322007141?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S2161831322007141?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.3945/an.116.013151"}],"createdAt":"2017-03-15","modifiedAt":"2025-10-31","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168308437248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Animal models for analyzing metabolic syndrome‐associated liver diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390565134816309120","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"腸管不全とシトルリン投与"}]},{"@id":"https://cir.nii.ac.jp/crid/1391975831234789120","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis          stratified by body mass index in patients with non-alcoholic fatty liver          disease"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3945/an.116.013151"},{"@type":"CROSSREF","@value":"10.1111/pin.12600_references_DOI_F2RAOPIPcHIG5CJovgKqy1JKia7"},{"@type":"CROSSREF","@value":"10.12938/bmfh.2020-046_references_DOI_F2RAOPIPcHIG5CJovgKqy1JKia7"},{"@type":"CROSSREF","@value":"10.11638/jssmn.53.6_301_references_DOI_F2RAOPIPcHIG5CJovgKqy1JKia7"}]}